PMV Pharmaceuticals to Participate at Upcoming Investor Conferences
May 23, 2025 16:05 ET | Source: PMV Pharmaceuticals, Inc. PRINCETON, N.J.,…
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular…